Visualizing the movement of angiocatheters during endovascular interventions is typically accomplished using x-ray fluoroscopy. There are many potential advantages to developing magnetic resonance imaging-based approaches that will allow three-dimensional imaging of the tissue/ vasculature interface while monitoring other physiologically-relevant criteria, without exposing the patient or clinician team to ionizing radiation. Here we introduce a proof-of-concept development of a magnetic resonance imaging-guided catheter tracking method that utilizes hyperpolarized silicon particles. The increased signal of the silicon particles is generated via low-temperature, solid-state dynamic nuclear polarization, and the particles retain their enhanced signal for ≥40 minutesallowing imaging experiments over extended time durations. The particles are affixed to the tip of standard medical-grade catheters and are used to track passage under set distal and temporal points in phantoms and live mouse models. With continued development, this method has the potential to supplement x-ray fluoroscopy and other MRI-guided catheter tracking methods as a zerobackground, positive contrast agent that does not require ionizing radiation.
, who not only have a much longer anticipated lifetime but also a greater potential for multiple procedures. Additional health concerns in patients that are attributed to the iodinated contrast media include nephropathy 8 and, less commonly, allergic reactions. Magnetic resonance imaging (MRI)-guided catheter tracking is attractive due to its many potential benefits, including three-dimensional imaging of the interactions between soft tissues and the vasculature without using ionizing radiation. The use of MRI-based catheter guidance also allows clinicians to simultaneously monitor other physiologically-relevant criteria, including metabolism, temperature, blood flow velocity, and tissue perfusion 9 . To date, typical MRI-guided catheter guidance approaches fall into one of two categories: active or passive tracking. The former method involves monitoring the active signal of a miniature radiofrequency (rf) coil placed near the catheter tip 10 , while the latter may examine susceptibility differences between paramagnetic dysprosium oxide rings embedded into the catheter versus that of nearby tissue 11 . Other passive MR catheter tracking techniques include T 1 -weighted imaging of a catheter filled with gadolinium 12 , or non 1 H-imaging of catheters filled with other contrast media (including 19 F imaging of perfluorooctylbromide 13 and 13 C imaging of hyperpolarized (HP) 13 C-labelled 2-hydroxyethylpropionate 14 ). While these methods offer contrast between the otherwise MR-invisible catheter and patient anatomy, they also suffer from inherent drawbacks that limit their applicability in the clinic. For example, active catheter tracking methods require specialized catheters and dedicated rf circuitry/equipment, while posing the risk of localized tissue heating and steering problems due to the inflexibility of the catheter tip 10 . While passive susceptibility tracking is a relatively simple process by comparison to active imaging, it usually provides negative contrast that is vulnerable to distortion artefacts 11 and also requires the use of a specialized catheter. T 1 -weighted imaging of gadolinium-filled catheters requires competition with a significant 1 H noise background and T 2 *-associated signal losses 12 . In the case of hyperpolarized 13 C tracer alternatives, a continuous supply of the contrast agent is required because these tracers naturally depolarize within a timeframe of 60 seconds, an effect that is hastened by magnetization-depleting rf pulses during signal acquisition 14 (a consequence that is true for all hyperpolarized media). Also, catheters that are filled with liquid MRI contrast agents (such as gadolinium or 19 F and 13 C tracers) cannot easily be used for simultaneously injecting other liquids into the body 13 without employing multi-lumen catheters, thereby limiting their clinical use for further diagnostic and/ or interventional procedures. A method of hyperpolarizing silicon micro-and nanoparticles has been recently demonstrated 15, 16 to increase 29 Si MR signals by up to 3-5 orders of magnitude via enhanced nuclear spin alignment, while retaining this improved signal for tens of minutes. Hyperpolarization of the 29 Si nuclear spins is generated by solid-state dynamic nuclear polarization (DNP), which uses low temperatures and high magnetic fields to spin-polarize an electron bath to near unity; this spin polarization is then transferred to nearby nuclear spins through microwave-mediated dipolar interactions 17 . DNP of solid (dry) silicon particles takes advantage of naturally-occurring electronic defects on the particle surfaces and obviates the need for additional radicals to generate the necessary free electrons 18 . The resulting increase in 29 Si nuclear spin polarization is relatively long-lasting (T 1 ~ 40 minutes) 15 compared to other hyperpolarized modalities (e.g., HP 13 C tracers) 19 , and is not affected by the in vivo environment. Silicon micro-and nanoparticles are non-toxic, non-radioactive, and have been investigated for biomedical applications due to their favorable biocompatibility and biodegradability 20 . Here, we use solid-state hyperpolarized silicon particles as a proof-of-concept for MRI-based catheter guidance in both phantoms and in vivo. We demonstrate catheter tracking both over long time durations (40 minutes) and in real time (refresh rate of 6.25 FPS), as well as two-dimensional and three-dimensional catheter guidance visualization. This method of passive catheter tracking provides background-free positive contrast using a standard medical-grade catheter and does not require the catheter to be filled with a liquid tracer. The biocompatible silicon particles are commercially available and would contribute minimally to the cost of the procedure (the work presented here required ~3¢ of silicon particles), and are hyperpolarized using a well-characterized 21 modality that has recently been made available for clinical studies of 13 C-labeled metabolic tracers 22 . With further development, this approach could have a situational clinical role as a non-ionizing, zero-background, positive contrast imaging agent for real-time catheter guidance using MRI.
Results
Catheter tracking over long time durations. Silicon particles (average mean diameter ~ 2 μ m) were packed into sample tubes and hyperpolarized in the solid state using a home-built DNP device. Following hyperpolarization, the particles were collected, quickly warmed to room temperature, and affixed to the tip of a medical grade catheter. For this study, two silicon samples were used: ~50 mg of particles loaded onto a 24 Fr urinary catheter (8 mm outer diameter, or 'OD'), and ~6 mg of particles loaded onto a 5 Fr angiocatheter (1.67 mm OD). Additional experimental criteria are available in the Materials and Methods section, as well as the Supplementary Material.
As an initial proof-of-concept, Fig. 1a shows positive contrast 29 Si images (co-registered with 1 H imaging) of the urinary catheter transiting ~4 cm through a gelatin phantom over the course of 40 minutes; this short distance is necessitated by the use of a 29 Si/ 1 H dual-tuned MRI coil that was designed for in vivo mouse studies (active region of coil only 52 mm in z-axis). The extended time scale over which the particles retain their increased magnetization is consistent with previous silicon micro-and nanoparticle Scientific RepoRts | 5:12842 | DOi: 10.1038/srep12842 studies 15, 23 , and is far greater than what is typically expected from other hyperpolarized species (e.g., T 1 of HP 13 C-labelled tracers is typically ≤1 minute) 24 . The ability to acquire images over this time duration supports this method's future development for potential utility in the clinic.
Multi-dimensional catheter tracking.
Following the initial catheter tracking demonstration using a large urinary catheter, we progressed to monitoring a medical-grade angiocatheter using roughly an order of magnitude fewer particles (corresponding to ~12% of the previously available magnetization). This 5 Fr catheter was tracked in two dimensions at distinct points over the course of ~4 cm and 28 minutes as it transited through a plastic Y-shaped hollow phantom to simulate guidance through the branching of the vasculature (specifically, for typical retrograde common femoral artery access with the catheter tip positioned above the level of the simulated aortic bifurcation; Fig. 1b ). Further visualization of angiocatheter maneuverability includes three-dimensional tracking through a spiral-shaped phantom ( Fig. 1c ; Supplemental Video S1).
In vivo catheter tracking. Given that the 5 Fr angiocatheter is similar in diameter to commercially available endoscopes used for mouse colonoscopies 25 as well as being a common size for human endovascular use, initial in vivo studies were carried out using the large intestine of a live mouse as a surrogate H imaging protocol ( Fig. 3 ; Supplemental Video S3) that shows the undulating of the intestines with the movement of the catheter. Regardless, the catheter is visualized moving in two dimensions ~3 cm through the intestinal tract of the mouse over the course of ~4 minutes (~2 cm in 22 min. for Fig. 3 ), demonstrating the first in vivo results using HP 29 Si particles for catheter guidance.
Real-time catheter tracking. Because continuous imaging is requisite for catheter tracking in the clinic, we demonstrated this technique using real-time 29 Si imaging of the urinary catheter transiting through a gelatin phantom ( Fig. 4 ; Supplemental Video S4). The co-registered images show the catheter moving ~5 cm over the course of 20 frames in ~3.2 seconds (only 11 of the 20 frames shown here), resulting in a frame rate of 6.25 FPS. These image refresh rates are comparable to those that are typically achieved using fluoroscopy-guided catheter tracking in the clinic 6 . Longer time durations of continuous imaging are also possible using the same allotment of hyperpolarized particles (as the experiment was successfully repeated immediately afterwards with the same sample; not shown).
Discussion
In this proof-of-concept study, we have demonstrated the viability of passive catheter tracking using hyperpolarized 29 Si MRI using both phantoms and mouse models, over long time durations and in real time, and in both two and three dimensions. This method provides radiation-free, background-free positive contrast over the course of > 40 minutes using non-specialized catheters that are tagged with a biologically safe media. While current limitations in The experiments presented here are limited by a reduced field of view that is inherent to small animal imaging coils that are designed for mouse imaging (35 mm inner diameter, or 'ID'; 52 mm homogenous rf region in z-axis); this is a result of the 29 Si DNP polarizer being situated in a small animal imaging facility without any clinical scanners in close proximity. Combined with this is a current lack of human-scale MRI detection coils that are tuned to the 29 Si resonance frequency. Another potential drawback is the non-renewable nature of hyperpolarized signal; which decays through both natural spin population redistribution over time, as well as through the application of magnetization-depleting rf pulses for image acquisition. The 29 Si signal in these particles can last for tens of minutes, which is on the same scale as most endovascular catheterization procedures. Also, the depletion of available magnetization upon the administration of rf pulses was mitigated by using small tipping angle pulses to minimally perturb the 29 Si spins. For early acquisitions, a Fast Low-Angle Shot (FLASH) sequence employed a ramped tipping angle to provide near-constant 29 Si signal intensities with each acquisition; the final image of the longer time duration experiments ended with a 90° Rapid Acquisition with Refocused Echos (RARE) sequence to maximize the amount of signal left at the end of the study. Given the short T 2 * of these silicon particles (~600 ms), additional gains could be achieved by employing a zero echo time (ZTE) imaging sequence to improve the signal-to-noise ratio with even smaller excitation pulses; it should also be noted that 29 Si MRI scans were completed with single scans (no averaging required) and use high reconstruction thresholding due to zero 29 Si signal background and a priori knowledge of the expected image profile. Furthermore, the long T 2 (1-2 s) of these could be taken advantage of in order to image more lines of k-space with fewer rf pulses, and future improvements to the imaging hardware (i.e., flexible phased-array coils) can also be used to maximize scanning time by mitigating the deleterious effects of image acquisition. With moderate improvements to the 29 Si hyperpolarization level, MR hardware, and pulse sequences, the spatial resolution in this study (~1 mm) may become more competitive with the current clinical standard of x-ray fluoroscopy (~0.1 mm).
Silicon-based micro-and nanoparticles have received recent interest as targeted diagnostic and drug delivery vehicles, due to their biocompatibility, biodegradability, and simple surface chemistry that is amenable to drug loading and targeting 20 . Because of this, they are favorable for development as platform nanotechnologies, where multiple targeting agents and therapeutic drugs can be attached to the particles surfaces for multiplexed theranostic applications. For this study, we chose larger silicon microparticles because of their longer T 1 compared to particles in the < 100 nm range (T 1 ~ 10-15 min). The ability to hyperpolarize these particles makes them amenable to in vivo MR imaging 15 ; since its gyromagnetic ratio is similar to those of 13 C and 15 N, the 29 Si resonance frequency is typically within the tuning range of commercial (multinuclear) MRI systems. Increasing interest in clinical 29 Si MRI may prompt the implementation of human-scale imaging coils that are resonant at the 29 Si precession frequency; these coils may be able to improve on relative sensitivity (neglecting filling factor) using phased-array receiver configurations. Future studies will look to utilize clinical MRI scanners and torso 29 Si imaging coils to expand the available field of view for catheter tracking.
The recent clinical demonstration of DNP of small 13 C-metabolites 22 in prostate cancer patients, along with ongoing clinical trials of silicon-based particles for drug delivery 26 , should help pave the way for rapid translation of hyperpolarized 29 Si MRI to the clinic. Although current versions of commercially-available clinical DNP devices are not marketed for silicon hyperpolarization, there should be no technical reason why it would not be feasible with minor alterations; in the future, using these devices for both 13 C metabolic studies and 29 Si molecular and interventional imaging could help defray hospital costs for access to hyperpolarized media. Furthermore, because the effects of hyperpolarization are field-independent, this technique is amenable for MRI at lower B 0 , as well as in open-configuration scanners that are more conducive to interventional procedures. For this proof-of-concept work, the sample tube of hyperpolarized silicon particles was either push-fit onto the end of the angiocatheter, or placed inside the end of the urinary catheter; while we did not physically alter the catheter in any way, we recognize that improvements in silicon particle placement will be key to further development. To that end, future studies will attempt to coat the entirety of the catheter in hyperpolarized silicon particles to permit visualization of the full catheter length (allowing bends and/or kinks to be monitored) while allowing the lumen to be used to inject contrast media, collect specimens, and conduct interventional operations and therapies. With further development, enhanced 29 Si MRI-guided catheter visualization may allow clinicians to perform concurrent diagnostic and interventional MRI studies without the need to shuttle patients from one imaging suite to another, decreasing patient residence time and increasing safety.
Materials and Methods

29
Si particles and catheters. Silicon particles (polycrystalline/amorphous; average mean diameter ~2 μ m) were commercially sourced (CAS No. 7440-21-3) and used as received (99.9985% elemental purity; 29 Si isotopic natural abundance of ~4.7%). The particles were packed into small Teflon tubes; one sample (used for phantom experiments) contained ~50 mg of particles packed into a 3 mm ID × 8 mm long tube and (following 29 Si DNP) was placed inside the existing opening near the tip of the large urinary catheter (24 Fr; 8 mm OD; Rochester Medical Corp.), while the other sample (used for phantom and mouse experiments) consisted of ~6 mg of particles packed into a 1.4 mm ID × 4.5 mm long tube and (following DNP) was push-fit onto the tip of the angiocatheter (5 Fr; 1.67 mm OD; Cook Medical). For hyperpolarization, the sample tubes were push-fit onto the end of a garolite rod and inserted into the DNP device (the smaller sample was placed inside of a larger sample tube, which was then push-fit onto the end of the garolite rod).
Si DNP. After insertion of the packed sample tubes into the home-build polarizer, DNP was performed at ~ 3.2 K and ~2.9 T. Polarization times typically ranged from 5 hours for the larger (50 mg) sample to 17 hours for the smaller (6 mg) sample; the deciding factor for polarization time was the ability to generate sufficient 29 Si signal to complete the imaging study (these silicon particles typically reached steady-state hyperpolarization after ~15 hrs of DNP). The 100 mW microwave source was frequency-modulated from 80.83 to 80.90 GHz using a 20 kHz ramp modulation, and directed to the sample via waveguide and slot antenna. Quality control was monitored using an on-board miniature NMR spectrometer to sample 29 Si polarization levels during DNP. The silicon particles can be quickly removed from the polarizer, warmed to room temperature, and affixed to the catheter tip without a significant loss in polarization; the low specific heat capacity (712 J/kg°C) and robust thermal conductivity (159 W/m°C) of silicon 27 allow the sample to be warmed by hand while transporting to the MRI scanner (T transport < 1 minute). The measured hyperpolarized relaxation rate of the silicon particles was ~25 minutes at 7 T and room temperature.
MRI experiments. All imaging experiments described here were performed in a 7 T horizontal-bore small animal scanner (Bruker Biospin), using Paravision software (v5.1; Bruker Biospin). A custom-made dual-tuned 1 H/
Si litz coil (Doty Scientific) was used for co-registered imaging (35 mm ID; homogenous rf region ~52 mm along z-axis). A small sample of silicon oil (1.5 ml; CAS: 63148-62-9) was used for calibration purposes; typical 29 Si nuclear spin polarization values ranged from 0.5-1.0%.
Si imaging was performed using Fast Low Angle Shot (FLASH) and Rapid Acquisition with Refocused Echoes (RARE) sequences;
1 H anatomical and phantom images used a RARE sequence in the coronal plane. Additional details of the imaging sequences and processing protocols are listed in the Supplementary Materials. Phantom experiments. Phantoms were positioned in the center of the homogenous rf region of the MRI coil, and the HP 29 Si -tagged catheter was moved through the phantom during imaging acquisitions. Phantoms consisted of gelatin inside a 50 ml centrifuge tube (Figs 1a and 4) , a 3-way plastic hose barb connector (Fig. 1b) , and a spiral groove etched into the side of a 32 mm diameter × 98 mm long cylindrical stock of PTFE (Fig. 1c) .
Mouse handling.
All animal studies were performed in accordance with animal use protocols that were approved by the UT MD Anderson Cancer Center "Institutional Animal Care and Use Committee" (IACUC). Wild type male APC (+/+) mice with a BL6 background (DOB 12/25/2013; sourced from MD Anderson Cancer Center) were used in all studies; these non-genetically modified mice (tail genotyping) were produced in an APC MIN breeding colony. These normal mice were anesthetized with 2% isoflurane (in 0.75 l/min oxygen) administered by an MR-compatible nose cone while the mouse was stationed on a custom cradle inside the MRI coil. The HP 29 Si -tagged 5 Fr angiocatheter was inserted ~3 cm into the rectum of the live mouse; it was then slowly pulled out in discrete intervals corresponding to the given imaging sequence. For Fig. 2 ; a single 1 H image was acquired after the series of 29 Si images. For Fig. 3 , alternating 29 Si and 1 H images were acquired. All mice survived the procedure with no evidence of ill effects.
